Background: Hongjingtian injection (HJT) is administered in the treatment of vascular diseases, including diabetic angiopathies (DA). However, its underlying mechanisms have not been examined systematically. Methods: In this research, we explored potential mechanisms of HJT through network pharmacology. HG-stimulated A7r5 cells served as the cell model. Cell proliferation, migration and apoptosis were investigated. The effects on key targets and the AKT pathway were verified by Western blotting in experiments with the AKT inhibitor LY294002 or activator SC79. Results: Network analysis predicted that HJT targeted 10 candidate targets and 15 pathways including cell proliferation, migration and apoptosis in response to DA. Functional experiments showed that HJT markedly suppressed the proliferation and migration and promoted the apoptosis of HG-induced VSMCs, which validated the prediction. Mechanistically, HJT significantly downregulated the expression of pAKT, MMP9, and PCNA, upregulated the expression of p53 and cleaved caspase-3 and increased the Bax/Bcl-2 ratio compared with the HG group. SC79, an AKT activator, partially reversed the inhibitory effects of HJT on HG-induced VSMCs, confirming the involvement of the AKT pathway. Furthermore, the presence of the AKT inhibitor LY294002 had a similar inhibitory effect as HJT. Conclusion: These findings systematically evaluate the potential mechanisms of HJT for the treatment of DA. HJT suppressed the proliferation and migration and promoted the apoptosis of HG-induced VSMCs partly by inhibiting the AKT pathway. Additionally, this study may provide a quick and effective way to investigate the molecular mechanisms of traditional Chinese medicine.
Introduction
The incidence of diabetes mellitus (DM) is rapidly increasing worldwide. 1 Diabetic angiopathies (DA), particularly atherosclerosis (AS), are the leading causes of disability and mortality in this large cohort of patients. 2 Although the mechanisms of DA are still incompletely understood, risk factors converge on the vascular wall, specifically vascular smooth muscle cells (VSMCs). 3 Hyperglycemia facilitates the proliferation and migration of VSMCs 4 and inhibits the apoptosis of VSMCs. 5 VSMC dysfunction promotes the growth of plaque volume, accelerates the deposition of extracellular matrix (ECM) and ultimately leads to vascular remodeling. 6 Therefore, targeting VSMCs might be a new option for the treatment of DA.
Hongjingtian injection (HJT) is manufactured from water-soluble extracts of Rhodiola wallichiana, and has been used to treat vascular diseases for many years in China. Clinical studies have shown that HJT improves hemorheology, reduces intima-media thickness and relieves atherosclerotic inflammatory reactions. 7, 8 However, the mechanism of HJT in the clinical application for DA therapy is not well understood. Due to its multicomponent, multitarget properties, it is challenging to elucidate the pharmacological effects of HJT. Fortunately, network pharmacology, which is based on systems biology and computer technology, is emerging as an efficient tool to illuminate complex interactions between drugs and biological systems. 9 In this study, both integrative network analysis and experimental verification were used. First, the potential targets of HJT were predicted by screening various databases. Then the candidate targets and potential mechanisms of HJT in the treatment of DA were analyzed. Ultimately, cell experiments were employed to verify the network analysis results (Figure 1 ).
Materials and Methods

Chemicals and Reagents
HJT was purchased from Tonghua Yusheng Pharmaceutical Co. Ltd. (Tonghua, China), which is a standardized medical product approved by the Sino Food and Drug Administration (SFDA) (Z20026866). HJT mainly consists of five ingredients: gallic acid, p-hydroxybenzoic acid, tyrosol, salidroside and p-hydroxycinnamic acid.
10,11 SC79 and LY294002 were purchased from MedChem Express (Monmouth Junction, USA). The concentration of SC79 was 2.5 μM 12 and the concentration of LY294002 was 10 μM.
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Screening for the Potential Therapeutic Targets of HJT in Diabetic Angiopathies
The corresponding targets of the five ingredients were obtained from three validated target databases, and three predicted target databases. ctdbase.org/). Only the Homo sapiens genes with the top 50 reference counts were chosen. Then, these genes were compared to the HJT-relevant genes to obtain the overlapping genes of HJT in the treatment of DA.
Network Construction
The following three visualized networks were constructed with Cytoscape 3.2.1.:
1. Drug-targets network (D-T network). The five components of HJT and their relevant targets generated the D-T network. 2. Drug-candidate targets network (D-C network).
The five ingredients of HJT and their candidate targets in the treatment of DA were included in the D-C network. 3. Protein-protein interaction network (PPI network).
The correlated proteins of candidate targets were obtained from the String database (http://string-db. org/). All these targets formed the PPI network. The topological property of the PPI network was analyzed and the targets with a degree greater than the average degree (6.83) were carried for further functional analysis.
Functional Analysis
The functional annotations of the critical targets were investigated by Database for Annotation, Visualization and Integrated Discovery (DAVID, http://david.abcc. ncifcrf.gov/). The cutoff criterion was set to a p-value <0.01. Additionally, the top 15 biological processes meeting the criterion were visualized by bubble charts.
Cell Culture and Treatments
A7r5 cells, 14 a rat thoracic aorta smooth muscle cell line, were obtained from Procell (Wuhan, China). The cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (all from Gibco, NY, USA). All cells were maintained in 5% CO 2 at 37°C under a humidified atmosphere. After serum starvation for 24 hrs, cells were exposed to DMEM containing 5. 
Cell Viability and Proliferation Analysis
Wound Healing Assay
VSMCs (1.5 × 10 5 /well) were seeded in six-well plates. A linear wound was made with a 10 μL pipette tip on the cell layer. PBS was used to remove the wounded cells. This time point was set as 0 hrs. VSMCs were then exposed to different treatments (MG, HG, HG + HJT10, HG + HJT20, or HG + HJT40) as indicated for 24, or 48 hrs. The scratch wound was imaged at 0, 24 and 48 hrs via microphotography. The wound healing rate was calculated by ImageJ. 16 
Transwell Assay
VSMCs were plated on six-well plates and treated with different media for 48 hrs. Then, the pretreated cells (1 × 10 5 /chamber) were seeded into the upper chamber (Corning, NY, USA) with 0.5% FBS DMEM. The lower chambers were filled with DMEM supplemented with 10% FBS. After incubation for six hours, VSMCs that had migrated to the lower chamber were stained by crystal violet. Cells were then counted in five randomly selected fields with a magnification of 200×.
Western Blotting
Electrophoresis was used to separate the proteins of VSMC lysates. The proteins were transferred onto membranes and incubated overnight with the appropriate primary antibody. The secondary antibody was then used to bind and visualize the primary antibody. Mouse anti-Bcl-2 (Sc-7382) was obtained from Santa Cruz Biotechnology (Dallas, USA); rabbit anti-MMP9(Ep1254) was obtained from Abcam(Cambridge, UK); rabbit anti-cleaved caspase-3 (Asp175), rabbit anti-AKT (C67E7), rabbit antiphospho-AKT (Ser473), rabbit anti-PCNA (D3H8P) and mouse anti-p53(1c12) were obtained from Cell Signaling Technology (Danvers, MA, USA); and mouse anti-Bax (Gb11007) was obtained from Servicebio (Wuhan, China).
Annexin V-FITC/Propidium Iodide Assay
Apoptosis was evaluated by an Annexin V-FITC/PI apoptosis assay kit (Neobioscience, Inc., Shenzhen, China). VSMCs were stimulated for 48 hrs, then adjusted to a density of 4.0 × 10 6 cells/mL and resuspended in 195 μL of binding buffer. Subsequently, the cells were stained with 5 μL of annexin V-FITC and 10 μL of propidium iodide for 10 mins. The rate of positive cells was identified by flow cytometry.
TUNEL Assay
A TUNEL Apoptosis Assay Kit (Beyotime Biotechnology, Shanghai, China) was used to assess apoptotic cells. VSMCs were cultured on glass coverslips and pretreated for 48 hrs as described above. Then, cells were subjected to the TUNEL assay and imaged (magnification, ×200).
Statistical Analysis
Statistical analysis was conducted using SPSS 21.0 software. The results are expressed as the mean ± SD. Student's t-test was performed to analyze the difference between the experimental and control groups. The oneway analysis of variance (ANOVA) test followed Turkey's posttest was used to analyze the difference among multiple groups. P value < 0.05 was regarded as significant.
Results
The Candidate Targets of HJT Against Diabetic Angiopathies
First, we identified 279 targets of HJT through the six target fishing database (Table S1 ). As shown in Figure 2A , the D-T network consisted of 284 nodes and 414 interactions. Second, we searched the CTD database with the keyword "diabetic angiopathies" and extracted the top 50 genes with the highest reference counts (Table S2 ). Finally, the 50 genes were mapped to the 279 genes to obtain the 10 candidate genes. They were VEGFA, AKT1, PTGS2, CASP3, BCL2, SERPINE1, TP53, BAX, ADRB1 and MMP9. Interestingly, salidroside, the main active compound of HJT, was associated with seven targets and might play an important role in DA treatment ( Figure 2B ).
PPI Network and Functional Analysis
Generating a PPI network has been used as an effective method to identify indirect targets. 17 As illustrated in Figure 3A , the PPI network was composed of 304 interactions involving the 10 candidate targets and 79 indirect targets. The nodes with larger degree values are usually the crucial targets in this network. Ultimately, 38 targets with a degree value greater than the average degree were selected as the critical targets (Table S3) .
To further annotate the targets, DAVID bioinformatics resources were used to analyze the biological process (BP) of the 38 crucial targets. Figure 3B demonstrates the top 15 gene functions of the critical targets. The top gene function was related to cell proliferation, which had the highest degree (degree=12). In addition to the apoptotic process (degree=11), cell migration (degree=9) and the phosphatidylinositol (PI)-mediated signaling pathway (degree=8) were regarded as the crucial biological processes of HJT in the regulation of DA. Interestingly, these processes all interacted with AKT, which implied that the AKT pathway might be the key pathway. 
HJT Significantly Inhibited the Proliferation of VSMCs Induced by HG
The CCK-8 assay was also used to assess VSMC proliferation. As shown in Figure 4B , HG stimulated the proliferation of VSMCs compared with MG (P<0.001), and HJT substantially suppressed HG-induced VSMC proliferation (P<0.05 vs HG) in a dose-dependent manner. The results showed that HGinduced proliferation was significantly lower by approximately 50% after 40 mL/L HJT stimulation. These data revealed that HJT could significantly suppress the HG-induced proliferation of VSMCs. 
HJT Inhibited the Migration of VSMCs Induced by HG
The Transwell assay and wound healing assay were performed to assess cell migration ( Figure 5 ). As expected, VSMC migration was markedly increased by HG (P<0.001 vs MG). However, HJT at concentrations of 20 and 40 mL/L significantly abolished the increased migration of VSMC (P<0.001 vs HG). Using the wound healing assay, HG significantly enhanced the VSMC migration of two folds for 48 hrs compared with MG. HJT prevented these increases in cells exposed to HG. These results indicated that HG promoted VSMC migration, and that HJT exhibited effective inhibitory activity on the migration of VSMCs.
HJT Reversed the Inhibitory Effect of HG on Apoptosis in VSMCs
The Annexin V-FITC staining and TUNEL assay were used to study the effects of HJT on cell apoptosis ( Figure 6 ). Decreased cell apoptosis was observed in the HG group compared with the MG group by the TUNEL assay. Treatment with HJT significantly increased VSMC apoptosis. In addition, HJT also significantly increased the Annexin V+/PIsubpopulation (early apoptotic cells) in VSMCs, whereas the Annexin V+/PI+ subpopulation (late apoptotic cells) did not significantly change. These data indicated that HG inhibited the apoptosis of VSMCs and that HJT significantly increased the apoptosis (mainly early apoptosis) of VSMCs.
Experimental Validation of Key Targets
The AKT pathway is often overactivated by HG 18 and is associated with cell proliferation, migration, and apoptosis.
To delineate the response of VSMCs under stimulation with HG, the phosphorylation of AKT (pAKT) was examined. HG significantly increased the pAKT/tAKT ratio (P<0.01 vs MG, Figure 7 ). HJT treatment significantly reduced the pAKT/tAKT ratio (P<0.05 vs HG). MMP9 and PCNA, the downstream factors of AKT in regulating cell migration and proliferation, were significantly upregulated by HG, while HJT suppressed the expression of MMP9 and PCNA at concentrations of 20 and 40 mL/L (P<0.05 vs HG). The inactivation of AKT induces p53 activation, causing alterations in Bcl-2 family proteins and caspase activation, which contribute to the proapoptotic signal. 19 The results indicated that HG reduced p53 activation, cleaved caspase-3 levels and the Bax/Bcl-2 ratio compared with those of the MG group (P<0.05, Figure 7 ). HJT at concentrations of 40 mL/L significantly increased the levels of p53 and cleaved caspase-3 and the Bax/Bcl-2 ratio (P<0.01 vs HG).
HJT Reversed HG-Induced Changes in VSMCs Partially Through the AKT Pathway
To investigate the potential mechanism of HJT in HG-induced VSMCs, the AKT pathway was evaluated. After incubation with SC79 for 48 hrs, as shown in Figure 8A , HG-induced cells treated with SC79 had significantly increased the expression of pAKT and MMP9, and reduced the level of cleaved caspase-3 and the Bax/Bcl-2 ratio compared with HG. Furthermore, the effects of HJT40 on VSMCs were partially reversed by treatment with SC79. We then measured the protein level of key targets under LY294002 stimulation. AKT phosphorylation was markedly decreased compared to that of the HG group (P<0.05, Figure 8B ) and was accompanied by reduced expression of MMP9 and PCNA and increased expression of p53, cleaved caspase-3 and Bax/Bcl-2 ratio. These effects of HG with LY294002 were similar to those of HG with 40 mL/L HJT. These results demonstrated that HJT could suppress proliferation and migration, and promote apoptosis of VSMCs through the AKT pathway, confirming the network analysis findings.
Discussion
Accumulating evidence has suggested that HG alters the balance of VSMC proliferation and apoptosis, stimulates proliferation and migration, and inhibits apoptosis, 20 which implies it could be one of the causes of DA. 21 VSMCs are involved in the pathogenesis of atherosclerosis by accelerating proliferation and migration toward the lesion, extracellular matrix generation and plaque progression. 22 Therefore, targeting VSMCs might be an effective strategy for treating diabetic vascular complications.
HJT has been applied for vascular disease therapy for many years. 23 Recent studies have revealed that five components of HJT 11 possess multiple pharmacological effects.
Salidroside, one of the active compounds of HJT, exerted remarkable inhibitory effects on VSMC proliferation. 24 According to Yang et al 25 gallic acid attenuated the proliferation of human umbilical artery smooth muscle cells (HUASMCs). Tyrosol may be an effective drug in preventing atherosclerotic processes. 26 Behrangi N also reported that p-hydroxycinnamic acid inhibited the gene expression of MMP9 in rats. 27 However, there has been no scientific research on the synergistic effects of HJT on VSMCs to our knowledge. Considering the multicomponent and multitarget characteristics of HJT, a network pharmacology approach 28, 29 was used to investigate the underlying mechanism of HJT for DA therapy. It was predicted that HJT could regulate cell proliferation, apoptosis, and migration processes via the AKT pathway by directly interacting the targets AKT, MMP9, CASP3, TP53, BCL2 and BAX. Based on the results of network pharmacology analysis, cell experiments were used to validate the predicted mechanisms. Consistent with previous findings, our results showed that HG promoted proliferation and migration, but inhibited apoptosis of VSMCs. However, these HGstimulated changes were significantly reversed by HJT. In addition, we investigated the underlying mechanism further.
AKT, an important factor in PI3K-initiated signal transduction pathways, is tightly related to cell survival and cell death. 30 Previous research reported that the AKT pathway participated in HG-induced VSMC proliferation, migration and apoptosis. 20 Aberrantly activated AKT upregulated the expression of PCNA and MMP9, 31 but downregulated the expression of p53. 32 The downstream factor MMP9, one of the essential components of matrix metalloproteinases, is involved in cell adhesion and migration. 33 As shown in our data, HJT suppressed the levels of pAKT, MMP9 and PCNA in HG-induced VSMCs. Inhibition of AKT activity, in turn, activates p53 and sequentially stimulates mitochondria-dependent apoptosis pathways. 34 The tumor suppressor p53 functions as a transcriptional factor to regulate the downstream Bcl-2 family. 35 The apoptosis-promoting protein Bax and antiapoptotic protein Bcl-2 are two of the most critical Bcl-2 family members. 36 The Bax/Bcl-2 ratio is an index of apoptosis, and its increase induces the activation of caspases-3 and ultimately results in apoptosis. 37 In this study, HG decreased the p53, cleaved caspase-3, and Bax/Bcl-2 ratio at the protein level. However, upregulation of p53 and caspase-3 expression and increase in the Bax/Bcl-2 ratio was observed following HJT treatment in VSMCs.
To investigate whether AKT pathways are involved in the effects of HJT on HG-induced changes in VSMCs, an activator and inhibitor of AKT were used. In this work, we found that HJT in combination with LY294002 had generally consistent inhibitory effects on HG-induced VSMCs. Similarly, SC79, a strong AKT agonist, partially reversed the neutralizing effects of HJT. These results indicated that HJT suppressed cell proliferation, migration and induced apoptosis partly through the AKT pathway.
Our study has limitations. Although VSMCs play an important role in vascular disease, we do not know whether the therapeutic action of HJT on DA is cell-type specific. Moreover, the suppression of proliferation and migration and the promotion of apoptosis in VSMCs by HJT was limited to the AKT pathway. However, other signaling pathways have also been reported in DA. These interesting questions require further investigation.
Conclusion
In summary, this research systematically illustrated for the first time the mechanisms of action of HJT for DA therapy. HJT exhibited antiproliferative, antimigratory and proapoptotic effects on HG-induced VSMCs partly by the inhibiting AKT pathway. These results may provide data support to support the clinical application of HJT for DA therapy.
